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Impact of Parenchymal Tuberculosis Sequelae on Mediastinal 
Lymph Node Staging in Patients with Lung Cancer
Because tuberculous (TB) involvement of mediastinal lymph nodes (LN) could cause false 
positive results in nodal staging of lung cancer, we examined the accuracy of nodal staging 
in lung cancer patients with radiographic sequelae of healed TB. A total of 54 lung cancer 
patients with radiographic TB sequelae in the lung parenchyma ipsilateral to the resected 
lung, who had undergone at least ipsilateral 4- and 7-lymph node dissection after both 
chest computed tomography (CT) and fluorodeoxyglucose (FDG)-positron emission 
tomography (PET)/CT were included for the analysis. The median age of 54 subjects was  
66 yr and 48 were males. Calcified nodules and fibrotic changes were the most common 
forms of healed parenchymal pulmonary TB. Enlarged mediastinal lymph nodes (short 
diameter > 1 cm) were identified in 21 patients and positive mediastinal lymph nodes were 
identified using FDG-PET/CT in 19 patients. The overall sensitivity and specificity for 
mediastinal node metastasis were 60.0% and 69.2% with CT and 46.7% and 69.2% with 
FDG-PET/CT, respectively. In conclusion, the accuracy of nodal staging using CT or FDG-
PET/CT might be low in lung cancer patients with parenchymal TB sequelae, because of 
inactive TB lymph nodes without viable TB bacilli.
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INTRODUCTION
Accurate nodal staging of lung cancer is crucial for deciding the 
optimal treatment, because patients with mediastinal lymph 
node metastases are generally offered chemotherapy rather than 
surgery (1). If enlarged lymph nodes or hot uptake on fluorode-
oxyglucose (FDG)-positron emission tomography (PET)/com-
puted tomography (CT) are observed in patients diagnosed with 
lung cancer, metastases to the lymph nodes should be suspected.
  However, mediastinal lymph nodes are one of the main sites 
of Mycobacterium tuberculosis in latent tuberculosis (TB) infec-
tion (2). The involvement of lymph nodes in TB also causes in-
creased lymph node size (3) because of the accumulation of 
stimulated phagocytes caused by surviving mycobacteria and 
the fusion of phagosomal compartments, with possible fibrotic 
changes (4). TB also causes hot uptake on FDG-PET because 
glucose metabolism is increased with the accumulation of FDG 
in the inflammatory phagocytes and macrophages in the gran-
ulation tissue (5). Thus, TB involvement of mediastinal lymph 
nodes could cause false-positive nodal staging, especially in 
patients with evidence of previous TB. In this study, we exam-
ined the accuracy of nodal staging in lung cancer patients with 
radiographic sequelae of healed TB. 
MATERIALS AND METHODS
The subjects screened for this study were patients who had un-
dergone surgical lung resection with lymph node dissection for 
the treatment of primary or metastatic lung cancer between Jan-
uary 2004 and December 2006 at the Seoul National University 
Hospital, a university-affiliated tertiary referral hospital. Among 
them, patients with radiographic TB sequelae ipsilateral to the 
resected lung were screened for the analysis. If fibrotic bands, 
small calcified nodules, or bronchiectasis in the upper lobes 
were observed on chest CT preoperatively, the patients were 
regarded as having healed TB (6, 7). Patients who underwent 
both chest CT and FDG-PET/CT before surgical resection and 
who underwent at least ipsilateral 4- and 7-lymph node dissec-
tion during the operation were finally included in the study.
  Medical records were reviewed, including the pathology re-
sults and radiographic examinations. On CT, mediastinal lymph 
node enlargement was defined as the presence of lymph nodes 
larger than 1 cm in their smallest diameter (7, 8). On FDG-PET/
CT, mediastinal nodes with increased glucose uptake satisfying 
both qualitative (greater than that of the surrounding tissue) and 
quantitative (a maximum standardized uptake value [SUV] ad-
justed for patient body weight of ≥ 3.0 with a distinct margin) Lee SH, et al.  •  Mediastinal TB Lymphadenopathy in Lung Cancer
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criteria were considered positive (9, 10). 
 
Diagnosis of mediastinal tuberculous lymphadenitis
The histology of the dissected lymph nodes stained with hema-
toxylin and eosin was reviewed. The presence of granulomas, 
with or without caseating necrosis, was confirmed. Additional-
ly, the results of acid-fast staining or the polymerase chain reac-
tion (PCR) for M. tuberculosis DNA were also screened when 
available. If acid-fast bacilli were seen in the specimen or PCR 
for M. tuberculosis DNA was positive, a definite diagnosis of TB 
lymphadenitis was made. If only a caseating granuloma was 
identified, we classified the specimen as probable TB lymphad-
enitis. We also classified patients who had granulomas with non-
specific necrosis as suspicious cases of TB lymphadenitis.
Diagnosis of mediastinal lymph node metastasis
During surgical resection, encountered lymph nodes were re-
moved from American Thoracic Society (ATS) lymph-node sta-
tions 10R, 9, 8, 7, 4R, 3, and 2R in tumors of the right lung and 
from stations 10L, 9, 8, 7, 6, 5, and 4L of the left lung (11). When 
necessary, station 1 (the highest mediastinal) or 2L (when tu-
mors were located in the left lung) nodes were also evaluated 
during the procedure. An experienced lung pathologist de-
scribed the location and number of lymph nodes according to 
the surgeons’ labeling of the dissected lymph nodes. Then, the 
pathologist evaluated the nodes for the presence or absence of 
tumor as numbered in the surgical field and reported the pres-
ence or absence of tumor in the nodes. Specimens were stained 
with hematoxylin and eosin, and then examined by light mi-
croscopy.
Ethics statement
The study protocol was approved by the institutional review 
board of the Seoul National University Hospital (H-0710-003-
221). Informed consent was waived in this study by the board.
 
RESULTS
During the study period, 796 patients with lung cancer under-
went surgical resection. Of these, 84 patients had radiographic 
TB sequelae ipsilateral to the resected lung. Among this latter 
group, the analysis included 54 patients for whom chest CT and 
FDG-PET/CT were available and the lymph node dissection 
included at least 4- and 7-lymph node sites.
  Of the 54 patients, 48 (88.9%) were males. Their median age 
was 66 (range 45-83) yr. Their mean body mass index was 22.1 ± 
2.7 kg/m
2. No patient was anti-HIV antibody seropositive. Four-
teen patients (25.9%) had a history of pulmonary TB and 42 pa-
tients (77.8%) were current or ex-smokers (Table 1). The most 
common pathological stage of the lung cancer was IB (18 pa-
tients, 33.3%). Mediastinal lymph node enlargement, larger 
than 1 cm in the smallest diameter on CT, was observed in 21 
patients (32.3%) and metastatic mediastinal lymph nodes were 
suggested by FDG PET/CT in 19 patients (29.2%).
  As seen in Table 1, calcified nodules (75.9%) and fibrotic 
changes (35.2%) were the most common forms of parenchymal 
Table 1. Demographic and clinical characteristics of lung cancer patients with TB 
sequelae in the ipsilateral lung who underwent surgery with lymph node dissection
Characteristics    Findings
No. of patients    54
Median age (range), yr   66 (45-83)
Sex (M:F) 48 (88.9%):6 (11.1%)
Body mass index (kg/m
2), mean ± SD 22.1 ± 2.7
Past history of tuberculosis    14 (25.9%)
Current or ex-smoker     42 (77.8%)
Positive HIV antibody 0 (0%)
Underlying disease
   Diabetes 
   Hypertension
   Chronic renal failure
   Gastric ulcer or early gastric cancer
   Chronic obstructive pulmonary disease
     7 (13.0%)
   15 (27.8%)
   1 (1.9%)
   4 (7.4%)
   2 (3.7%)
Pathologic stage of lung cancer
   IA
   IB
   IIA
   IIB
   IIIA
   IIIB
   IV
   Other cancer metastasis to the lung
 
   11 (20.4%)
   18 (33.3%)
   1 (1.9%)
     6 (11.1%)
   10 (18.5%)
   4 (7.4%)
0 (0%)
   4 (7.4%)
Operation site
   Right
   Left
   39 (72.2%)
   15 (27.8%)
Radiographic characteristics of lesions suggesting old healed TB
   Fibrotic change                                                                      19 (35.2%)
   Calcified nodule                                                                     41 (75.9%)
   Bronchiectasis                                                                       10 (18.5%)
   Calcified lymph nodes                                                              7 (13.0%)
Table 2. Pathological diagnosis of the dissected lymph nodes with positive findings on 
CT and FDG-PET/CT among patients who had undergone both CT and FDG-PET/CT
Variables
Lymph node in CT and FDG-PET/CT
CT findings FDG-PET findings
Positive* Negative Positive
† Negative
Patients number   21      33    19      35
Excised LN No., total 219 1,024  158 1,129
Excised LN No., per patient 1-31 11-49 1-25 11-76
Patients with metastatic  
   mediastinal lymph node
    9        6     7        8
Patients with definite TB   
   mediastinal lymph node
‡
    0        1     0        1
Patients with suspicious TB  
   mediastinal lymph node
§
    0        2     1        1
*The presence of lymph nodes ≥ 1 cm in their smallest diameter was considered to 
be positive on CT; 
†The presence of lymph nodes with a maximum SUV ≥ 3.0 was 
considered to be positive on FDG-PET/CT; 
‡Granulomas and acid-fast bacilli were 
observed on microscopic evaluation in one patient only; 
§Only granulomas were 
observed on microscopic evaluation in two patients. CT, computed tomography; FDG-
PET, fluorodeoxyglucose-positron emission tomography; LN, lymph node; SUV, 
standardized uptake value; TB, tuber  culosis.Lee SH, et al.  •  Mediastinal TB Lymphadenopathy in Lung Cancer
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lesions, and bronchiectatic changes in the upper lobes were 
found in ten patients (18.5%). Using the above-mentioned cri-
teria, lymph node enlargement was found in 21 patients and 
calcified lymph nodes were seen in seven.
  The median number of dissected lymph nodes per patient 
was 32 (range, 1-76). Of the 21 patients with enlarged mediasti-
nal lymph nodes on CT, nine were confirmed to have mediasti-
nal lymph node metastasis. In contrast, six of the 33 patients 
with negative CT findings were confirmed to have mediastinal 
lymph node metastasis; one of these patients was confirmed to 
have TB lymphadenitis, based on the presence of acid-fast ba-
cilli. Of the 19 patients with positive mediastinal lymph nodes 
by FDG PET/CT, seven were confirmed to have mediastinal 
lymph node metastasis. Eight of the 35 patients with a negative 
FDG-PET/CT were confirmed to have mediastinal lymph node 
metastasis; one of these patients was confirmed to have TB 
lymphadenitis by the presence of acid-fast bacilli. 
  On a per-person basis, the overall sensitivity, specificity, ac-
curacy, positive predictive value, and negative predictive value 
for mediastinal nodal metastasis were 60.0%, 69.2%, 66.7%, 42.9%, 
and 81.8% for CT and 46.7%, 69.2%, 63.0%, 36.8%, and 77.1% for 
FDG-PET/CT, respectively (Table 2). 
 
DISCUSSION
Our study involving lung cancer patients with TB sequelae 
showed that the accuracy of mediastinal staging using CT and 
FDG-PET/CT was low (66.7% and 63.0%), compared with pre-
vious reports from Korea (83.0% and 90.0%) (12). Especially, 
the specificity of mediastinal nodal staging using CT and FDG-
PET/CT for nodal metastasis was considerably lower in our 
study (69.2% for both tests), compared to 89% and 100% in a 
previous report for Korea (12), and 93% and 98% in a report for 
low TB burden country (13). 
  Although definite TB involvement was identified only in one 
patient and suspicious TB in two patients, the lower specificity 
for nodal metastasis in our study could be explained by TB in-
volvement. In patients with previous TB, mediastinal lymph 
node enlargement might represent inflammation of previously 
normal nodes draining areas of active TB in the lungs to other 
sites. These lymph nodes were defined as inactive TB lymph-
adenopathy (7). In previous reports, live TB bacilli could not be 
cultivated from the majority of inactive TB lesions (15). In fact, 
according to a previous report, as many as 77% of 78 lung can-
cer patients with calcified mediastinal lymph nodes were con-
firmed not to have cancer metastasis or definite TB lymphade-
nitis (14). Therefore, we can consider preoperative surgical stag-
ing to mediastinal lymph nodes in lung cancer patients with 
parenchymal TB sequelae, even though they have positive me-
diastinal lymph nodes in the chest CT and/or FDG-PET/CT.
  Because only one of the 54 patients with radiographic TB se-
quelae was diagnosed as having definite mediastinal TB lymph-
adenitis, it is possible that mediastinal lymph nodes are rarely a 
focus of latent TB infection, contrary to the general assumption. 
That is, this observation indicates that mediastinal lymph nodes 
are not likely a focus of TB reactivation in patients with healed 
TB who belong to the supposed high-risk group for reactivation 
of TB (16).
  Our data differ from a report from Turkey, which showed a 
5.1% prevalence of mediastinal TB among lung cancer patients 
regardless of previous TB sequelae shown on chest radiographs 
(17). Although the reason for the difference between the two 
studies is unclear, the fact that a considerable portion of our pa-
tients (26%) had been treated for pulmonary TB could result in 
the lower prevalence of the presence of TB bacilli in our study.
  To appreciate our results correctly, we should consider sev-
eral limitations of the study that might have underestimated the 
actual prevalence of mediastinal TB. First, not all mediastinal 
lymph nodes were resected and reviewed because this study 
was performed retrospectively. Additionally, acid-fast staining 
and PCR for M. tuberculosis DNA without mycobacterial culture 
for the diagnosis of TB might be insufficient for detecting the 
presence of mediastinal TB. Thus, the prevalence of mediasti-
nal TB could have been underestimated. A well-designed pro-
spective study is needed to determine the actual prevalence of 
mediastinal TB in patients with radiographic sequelae of healed 
TB.
  In conclusion, the accuracy of nodal staging using CT or FDG-
PET/CT is low in lung cancer patients with parenchymal TB se-
quelae, because of inactive TB lymph nodes without viable TB 
bacilli. 
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